MaxiVAX and Minaris Regenerative Medicine... Swiss cancer vaccine specialist MaxiVAX SA has hired Minaris Regenerative Medicine GmbH to produce its cell therapy MVX-ONCO-2. more ➔
EU orders additional COVID-19 vaccine dos...Pfizer Inc. and BioNTech SE have signed an agreement with the European Commission (EC) to supply an additional 200 million doses of BNT162b2 to the EU. more ➔
Novel strategy targets chronic liver disea...A resesarch team headed by HepaRegeneriX Board Member Lars Zender has presented a new approach to treat hepatocellular carcinoma (HCC) by disturbing the lipid metabolism of tumour cells. more ➔
Cellectis and Cytovia in US$760m licence d...Cell therapy specialist Cytovia Therapeutics Inc and genome editing expert Cellectis SAS partner to develop iPSC-derived natural killer (NK) cell-based cancer therapies. more ➔
Cellink AB acquires Ginolis Oy for €70mCellink AB will take over all shares of Ginolis Oy, a Finnish company focusing on diagnostics automation and advanced robotics solutions for medical and diagnostic industries. more ➔
Rentschler Biopharma launches gene therapy...CDMO Rentschler Biopharma will establish a Center of Excellence for cell and gene therapy through a new UK subsidiary Rentschler ATMP Ltd. more ➔
InteRNA Technologies secures €18.5m in S...MicroRNA-based therapeutics developer InteRNA Technologies has closed an extended Series B round totaling €18.5m led by AurorA Science, an Italian biotech investment company. more ➔
German Health Ministry to invest €6.2bn...The German Health Ministry has requested €6.2bn from the Federal Ministry of Finance to purchase up to 635 million additional doses of COVID-19 vaccines. more ➔
V-Bio Ventures launches second fund at €...V-Bio Ventures has announced the first closing of its V-Bio Fund 2 at €78m. The fund is focussed on investments into early stage life sciences companies in Belgium and the EU. · more ➔
Abingworth raises US-$465m for new life sc...The transatlantic Abingworth Bioventures 8 Fund has been closed at $464m to invest in US, UK and European life science companies. more ➔
